IRIS
ORLANDONI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.783
EU - Europa 897
AS - Asia 357
AF - Africa 41
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.082
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.780
UA - Ucraina 225
SE - Svezia 128
SG - Singapore 127
IT - Italia 123
IE - Irlanda 118
TR - Turchia 98
DE - Germania 96
DK - Danimarca 87
CN - Cina 79
FI - Finlandia 48
KR - Corea 46
FR - Francia 38
CI - Costa d'Avorio 36
GB - Regno Unito 19
BE - Belgio 5
MA - Marocco 5
CA - Canada 3
CH - Svizzera 3
HK - Hong Kong 3
IN - India 3
CL - Cile 2
AL - Albania 1
BG - Bulgaria 1
EE - Estonia 1
EU - Europa 1
IS - Islanda 1
JP - Giappone 1
LV - Lettonia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
Totale 3.082
Salva come PNG Salva come JPEG
Città #
Jacksonville 233
Chandler 229
Fairfield 205
Dublin 118
Wilmington 102
Boardman 101
Ashburn 100
Woodbridge 86
Seattle 73
Houston 71
Singapore 65
New York 61
Ann Arbor 52
Cambridge 51
Lawrence 47
Princeton 47
San Mateo 47
Turin 47
Abidjan 36
San Diego 20
Des Moines 15
Beijing 10
Centro 9
Shanghai 9
Izmir 8
Buffalo 7
Falls Church 7
Guangzhou 7
Ancona 6
Wuhan 6
Brussels 5
London 5
Naples 5
Los Angeles 4
Norwalk 4
Wuxi 4
Campobasso 3
Dallas 3
Helsinki 3
Hong Kong 3
Kilburn 3
Pune 3
Redmond 3
San Jose 3
Zurich 3
Chiswick 2
Clifton 2
Ottawa 2
Palermo 2
Scandicci 2
Simi Valley 2
Vallefoglia 2
Venice 2
Washington 2
Acton 1
Auburn Hills 1
Auckland 1
East Los Angeles 1
Hangzhou 1
Islington 1
Jiaxing 1
Jinan 1
Kunshan 1
La Canada Flintridge 1
Ljubljana 1
Longyan 1
Macerata 1
Nanjing 1
North Bergen 1
Ozzano Monferrato 1
Pesaro 1
Porto 1
Prescot 1
Reykjavik 1
Riga 1
Seoul 1
Solon 1
Taiyuan 1
Tallinn 1
Tiantai Chengguanzhen 1
Tirana 1
Toronto 1
Yiwu 1
Totale 1.976
Salva come PNG Salva come JPEG
Nome #
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 131
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 131
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 92
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 82
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 81
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 81
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 79
EFFECT OF PLATELET RICH PLASMA CONCENTRATION ON SKELETAL MUSCLE REGENERATION: AN EXPERIMENTAL STUDY 79
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 78
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 76
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 76
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 74
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 73
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 73
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 73
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 71
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 71
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 70
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 70
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 69
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 69
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 67
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 66
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 64
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 62
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 62
Potential application of berberine in the treatment of Escherichia coli sepsis 62
Vitamin E improves the in vivo efficacy of tigecycline and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus. 61
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 61
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 61
New evidence and insights on dalbavancin and wound healing in a mouse model of skin infection 60
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 58
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 56
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 54
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 54
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 53
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 53
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 52
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 52
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 52
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 52
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 51
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 49
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 46
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 45
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 44
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 42
Totale 3.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.025
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.025
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020224 0 0 0 0 46 1 44 0 46 7 5 75
2020/2021762 53 76 103 12 74 60 87 53 72 63 69 40
2021/2022395 31 89 0 4 6 38 23 13 26 65 18 82
2022/2023668 67 84 55 44 49 77 0 28 163 3 81 17
2023/2024334 67 13 15 57 57 80 3 4 0 3 5 30
2024/2025287 115 57 47 36 32 0 0 0 0 0 0 0
Totale 3.138